BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18342009)

  • 1. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
    Hitotsumatsu O; Ahmad RC; Tavares R; Wang M; Philpott D; Turer EE; Lee BL; Shiffin N; Advincula R; Malynn BA; Werts C; Ma A
    Immunity; 2008 Mar; 28(3):381-90. PubMed ID: 18342009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α-Induced NOD2 and RIP2 Contribute to the Up-Regulation of Cytokines Induced by MDP in Monocytic THP-1 Cells.
    Chen X; Xiao Z; Xie X; Liu X; Jiang M; Yuan C; Yang L; Hu J
    J Cell Biochem; 2018 Jul; 119(7):5072-5081. PubMed ID: 28639322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
    Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
    J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.
    Bist P; Cheong WS; Ng A; Dikshit N; Kim BH; Pulloor NK; Khameneh HJ; Hedl M; Shenoy AR; Balamuralidhar V; Malik NBA; Hong M; Neutzner A; Chin KC; Kobayashi KS; Bertoletti A; Mortellaro A; Abraham C; MacMicking JD; Xavier RJ; Sukumaran B
    Nat Commun; 2017 Jun; 8():15865. PubMed ID: 28656966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide.
    Windheim M; Lang C; Peggie M; Plater LA; Cohen P
    Biochem J; 2007 Jun; 404(2):179-90. PubMed ID: 17348859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, promotes TNF-α production via nucleotide-binding oligomerization domain containing 2 (Nod2)-dependent NF-κB activation in RAW264.7 cells.
    Katsunuma K; Yoshinaga K; Ohira Y; Eta R; Sato T; Horii T; Tanaka T; Takei M; Seto K
    Mol Immunol; 2015 Mar; 64(1):218-27. PubMed ID: 25499802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.
    Sicard P; Jacquet S; Kobayashi KS; Flavell RA; Marber MS
    Cardiovasc Res; 2009 Jul; 83(2):277-84. PubMed ID: 19213760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.
    Turer EE; Tavares RM; Mortier E; Hitotsumatsu O; Advincula R; Lee B; Shifrin N; Malynn BA; Ma A
    J Exp Med; 2008 Feb; 205(2):451-64. PubMed ID: 18268035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.
    Duong BH; Onizawa M; Oses-Prieto JA; Advincula R; Burlingame A; Malynn BA; Ma A
    Immunity; 2015 Jan; 42(1):55-67. PubMed ID: 25607459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nod2-Rip2 Signaling Contributes to Intestinal Injury Induced by Muramyl Dipeptide Via Oligopeptide Transporter in Rats.
    Ma G; Shi B; Liu J; Zhang H; YinTao Z; Lou X; Liang D; Hou Y; Wan S; Yang W
    Dig Dis Sci; 2015 Nov; 60(11):3264-70. PubMed ID: 26138652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.
    Bertrand MJ; Doiron K; Labbé K; Korneluk RG; Barker PA; Saleh M
    Immunity; 2009 Jun; 30(6):789-801. PubMed ID: 19464198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.
    Tigno-Aranjuez JT; Asara JM; Abbott DW
    Genes Dev; 2010 Dec; 24(23):2666-77. PubMed ID: 21123652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.
    Wu J; Zhang Y; Xin Z; Wu X
    Mol Immunol; 2015 Apr; 64(2):235-43. PubMed ID: 25549945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
    Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
    Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.